Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAXIBOTULINUMTOXIN A-LANM vs DEFEROXAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAXIBOTULINUMTOXIN A-LANM vs DEFEROXAMINE: Safety Overview

Metric DAXIBOTULINUMTOXIN A-LANM DEFEROXAMINE
Total FAERS Reports 891 839
Deaths Reported 0 152
Death Rate N/A 18.1%
Hospitalizations 5 314
Average Patient Age 43.1 yrs 41.9 yrs
% Female Patients 97.3% 59.1%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A INTRAMUSCULAR
Marketing Status N/A Prescription